Case Study: Large Pharmaceutical Company reduces R&D timelines and costs with Clinical Ink SureSource

Delivering Data in Minutes with Remote Monitoring to Reduce R&D Timelines, Costs

A large pharmaceutical company conducting an early Phase I study needed real-time, remote access to trial data, along with a way to eliminate manual data re-entry, reduce errors, and support remote monitoring of research sites. It worked with Clinical Ink and its SureSource eSource platform to address those needs.

Clinical Ink developed a customized eSource study that captured subject data electronically during visits, validated it on the tablet, and then transferred it to the clinical study database. Within one hour of a completed visit, the sponsor could remotely access and visualize the data, down from a nearly two-week wait, and nearly 80% of monitoring activities were completed remotely.